DMYD-B Diamyd Medical AB (publ)

STO · SE · Healthcare · Biotechnology · diamyd.com

0.9640SEK+2.34%Mkt Cap: 13.96M $P/E: —Today

Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy, which is in phase III clinical trial for the treatm…

Key Statistics

Company

Market Cap13.96M USD

Enterprise Value-18.28M USD

Revenue (TTM)41.32K USD

Gross Profit-354.39K USD

Net Income (TTM)-16.24M USD

Revenue/Share0.0030 SEK

Last Price0.9640 SEK

Fiscal Year EndAug 2025

MR QuarterMay 2026

Employees44

CountrySE

SectorHealthcare

IndustryBiotechnology

ISINSE0005162880

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA0.68

EV/Revenue-442.41

P/S358.76

P/B0.60

EPS (TTM)-2.00

EPS (Forward)—

52W Range

0.89600% of range17.88

52W High17.88 SEK

52W Low0.8960 SEK

Profitability

Gross Margin0.00%

Oper. Margin-181711.43%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-60.64%

ROA-44.56%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.26M USD

CapEx (TTM)—

FCF Margin-39123.29%

FCF Yield-115.77%

Net Debt-33.11M USD

Net Debt/EBITDA1.23

Balance Sheet

Debt/Equity—

Current Ratio15.50

Quick Ratio15.41

Book Value/Sh1.67 SEK

Cash/Share2.23 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.151.48M

Float132.05M

Insiders14.25%

Institutions23.41%

Technical

SMA 501.026 (-6.1%)

SMA 2005.437 (-82.3%)

Beta2.20

S&P 52W Chg16.45%

Avg Vol (30d)758.75K

Avg Vol (10d)1.29M

Technical Indicators

RSI (14)37.1

MACD-0.0116

MACD Signal-0.0047

MACD Hist.-0.0069

BB Upper1.092 SEK

BB Middle1.019 SEK

BB Lower0.9453 SEK

BB Width14.42%

ATR (14)0.0643 SEK

Vol Ratio (20d)1.60x

DMYD-B Diamyd Medical AB (publ)

Industry Peers

Key Statistics